New drug shows promise for back pain from ankylosing spondylitis
NCT ID NCT07277179
First seen Jan 09, 2026 · Last updated May 20, 2026 · Updated 24 times
Summary
This study tested a drug called netakimab in 113 Chinese adults with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. Participants received either netakimab or a placebo to see if the drug could reduce symptoms. The main goal was to measure a 40% improvement in disease activity at 16 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.